Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
CN Stock MarketDetailed Quotes
002675 Yantai Dongcheng Biochemicals
- 12.57
- 0.000.00%
Not Open Jan 23 15:00 CST
10.37BMarket Cap114.27P/E (TTM)
12.70High12.52Low50.78KlotVolume12.61Open12.57Pre Close63.96MTurnover0.68%Turnover Ratio49.49P/E (Static)824.60MShares16.2952wk High2.32P/B9.34BFloat Cap11.2852wk Low13.83Limit Up743.34MShs Float28.88Historical High11.31Limit Down1.43%Amplitude2.16Historical Low0.18Dividend TTM12.59Avg Price24.87KlotAsk1.39%Div YieldTTM100Lot Size24.37KlotBid
Yantai Dongcheng Biochemicals News
Dongcheng Pharmaceutical: Announcement of Resolutions of the 7th Meeting of the 6th Board of Directors
Dongcheng Pharmaceutical: Announcement on the change of accounting firm
Dongcheng Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the Sixth Board of Supervisors
Dongcheng Pharmaceutical: Announcement on the subsidiary\'s product 177Lu-LNC1004 being developed to obtain FDA Fast Track qualification
Dongcheng Pharmaceutical: Announcement of Supervisory Committee Resolutions
Dongcheng Pharmaceutical: Announcement of Board Resolutions
Dongcheng Pharmaceutical: Announcement on progress in providing guarantees for subsidiaries and their subsidiaries
Dongcheng Pharmaceutical: 002675 Dongcheng Pharmaceutical Investor Relations Management Information 20240902
Dongcheng Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement
Dongcheng Pharmaceutical: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Dongcheng Pharmaceutical: Semi-Annual Report Board Resolution Announcement
Yantai Dongcheng Biochemicals: Announcement regarding the subsidiary company obtaining a drug clinical trial approval notification.
Yantai Dongcheng Biochemicals: Announcement on the Progress of Providing Guarantees for Subsidiaries and Their Subsidiaries.
Yantai Dongcheng Biochemicals: 002675 Dongcheng Pharmaceutical Investor Relations Management Information 20240508
Yantai Dongcheng Biochemicals: Notice on subsidiary companies obtaining approval notices for drug clinical trials
Yantai Dongcheng Biochemicals: 2023 Annual Audit Report
Yantai Dongcheng Biochemicals: Announcement on 2024 Company and Subsidiaries Applying for Credit Lines from Banks
Yantai Dongcheng Biochemicals: 2023 Independent Director Debriefing Report (Zhao Dayong)
Yantai Dongcheng Biochemicals: Announcement of Supervisory Board Resolutions
Yantai Dongcheng Biochemicals: Opinions of Minsheng Securities Co., Ltd. on the deposit and use of funds raised by Yantai Dongcheng Pharmaceutical Group Co., Ltd. in 2023